Richards Group (RIC) Q4 2025 earnings summary

Executive summary

• Fiscal 2025 was a transition year, marked by a strategic shift from dividend distributions to growth, with a focus on profitability and high-quality assets.

• The company completed significant M&A activity, expanding its healthcare segment and global reach, and rebranded as Richards Group to reflect its dual focus on healthcare and packaging.

• A three-year plan (Transform, Perform, Present) was reviewed, with new long-term phases (Globalize, Optimize) introduced, extending the strategy to 2030.

Financial highlights

• Revenue increased 5.5% year-over-year, driven by healthcare acquisitions, but offset by declines in organic healthcare and food/beverage.

• Adjusted EBITDA declined 1% to 13% of revenue due to higher people costs and integration expenses.

• Q4 revenue accelerated by 5.8% over prior year; gross margins rose to 44.4% with healthcare acquisitions.

• Adjusted free cash flow fell by CAD 4.6 million to CAD 34.9 million, impacted by higher interest and maintenance capital.

Outlook and guidance

• The company is shifting focus to profitable growth, maintaining strong margins and cash flow.

• Long-term strategy includes global expansion of OEM brands and distribution, with targeted growth in Europe, Asia, Oceania, and South America.

• Optimization of real estate and organizational structure is planned for 2029–2030.